Company Overview of Attenuon, LLC
Attenuon, LLC, a clinical-stage biopharmaceutical company, develops cancer therapeutics to disrupt cellular signaling processes to tumor growth and metastatsis. It offers ATN-224 that disrupts signaling pathways involved in tumor growth, angiogenesis, and metastasis, including those mediated by multiple kinases, as well as NF-kappaB by inhibiting the enzyme superoxide dismutase; and ATN-161, a five-amino acid peptide derived from fibronectin. The company was founded in 1998 and is based in San Diego, California.
11535 Sorrento Valley Road
San Diego, CA 92121
Founded in 1998
Key Executives for Attenuon, LLC
Similar Private Companies By Industry
|Humanetics Corporation||United States|
|Atley Pharmaceuticals, Incorporated||United States|
|Syndexa Pharmaceuticals Corporation||United States|
|Acylin Therapeutics, Inc.||United States|
|Abbott Health Products, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Attenuon, LLC, please visit www.attenuon.com. Company data is provided by Capital IQ. Please use this form to report any data issues.